Common use of Regulatory Authority Clause in Contracts

Regulatory Authority. The term “Regulatory Authority” shall mean any national, supranational (e.g., the European Commission, the Council of the European Union, the European Medicines Agency), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country involved in the granting of Regulatory Approval for the Product.

Regulatory Authority. The term “Regulatory Authority” shall mean any national, supranational (e.g., the European Commission, the Council of the European Union, the European Medicines Agency), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity entity, including the FDA, in each country involved in the granting of Regulatory Approval for the Product.

Regulatory Authority. The term “Regulatory Authority” shall mean Authority means any nationalnational (e.g., supranational the FDA), supra-national (e.g., the European Commission, the Council of the European Union, or the European Medicines AgencyEMA), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country authority involved in the granting of Regulatory Approval Approvals or Price Approvals for the Productpharmaceutical products in such country or countries.

Regulatory Authority. The term “Regulatory Authority” shall mean any national, supranational (e.g., the European Commission, the Council of the European Union, the European Medicines Agency), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country involved in the granting of Regulatory Approval for the Collaboration Product.

Regulatory Authority. The term “Regulatory Authority” shall mean any nationalnational (e.g., supranational the FDA), supra-national (e.g., the European Commission, the Council of the European Union, or the European Medicines Agency), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country of the world involved in the granting of Regulatory Approval for the Product.

Regulatory Authority. The term “Regulatory Authority” shall mean means any applicable supranational, national, supranational (e.g., the European Commission, the Council of the European Union, the European Medicines Agency), regional, state state, provincial or local regulatory agencyagencies, departmentdepartments, bureaubureaus, commissioncommissions, council councils or other governmental entity including government entities, such as the FDA, regulating or otherwise exercising authority with respect to the Development Services or CTM Manufacturing ​ ​ of the Product and the production, interstate or international shipment, marketing, or sale of the Product or use of the Product in each country involved in the granting of Regulatory Approval for the Productclinical trials.

Regulatory Authority. The term “Regulatory Authority” shall mean any nationalnational (e.g., supranational the FDA), supra-national (e.g., the European Commission, the Council of the European Union, or the European Medicines AgencyAgency for the Evaluation of Medicinal Products), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country Governmental Body involved in the granting of a Regulatory Approval for the Productsuch country or countries.

Regulatory Authority. The term “Regulatory Authority” shall mean mean, with respect to a country in the Territory, any nationalnational (e.g., supranational the FDA), supra-national (e.g., the European Commission, the Council of the European Union, or the European Medicines AgencyAgency for the Evaluation of Medicinal Products), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country involved in the granting of a Regulatory Approval for the Productsuch country or countries.

Regulatory Authority. The term “Regulatory Authority” shall mean any national, supranational (e.g., the European Commission, the Council of the European Union, the European Medicines Agency), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country involved in the granting of Regulatory Approval for the Producta Companion Diagnostic.

Regulatory Authority. The term “Regulatory Authority” shall mean means any applicable supranational, national, supranational (e.g., the European Commission, the Council of the European Union, the European Medicines Agency), regional, state state, provincial or local regulatory agency, department, bureau, commission, council or other governmental government entity including regulating or otherwise exercising authority with respect to the Manufacturing of Product and the production, interstate or international shipment, marketing, or sale of the Product such as the United States Food and Drug Administration (FDA, ) or European Medicines Agency (EMA) or other jurisdictions agreed in each country involved writing in the granting of Regulatory Approval for the Productaccord with this Agreement.

Regulatory Authority. The term “Regulatory Authority” shall mean any national, supranational (e.g., the European Commission, the Council of the European Union, the European Medicines Agency), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDAFDA and EMA, in each country involved in the granting of Regulatory Approval for the Product.

Regulatory Authority. The term “Regulatory Authority” shall mean means, with respect to a country in the Territory, any nationalnational (e.g., supranational the FDA), supra-national (e.g., the European Commission, the Council of the European Union, or the European Medicines AgencyAgency for the Evaluation of Medicinal Products), regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity including the FDA, in each country involved in the granting of a Regulatory Approval for the Productsuch country or countries.